Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Pure red cell aplasia due to follow-on epoetin.

× No keyword cloud information.

6 in total

1. Biosimilars-why terminology matters.

Authors: Martina Weise; Marie-Christine Bielsky; Karen De Smet; Falk Ehmann; Niklas Ekman; Gopalan Narayanan; Hans-Karl Heim; Esa Heinonen; Kowid Ho; Robin Thorpe; Camille Vleminckx; Meenu Wadhwa; Christian K Schneider
Journal: Nat Biotechnol Date: 2011-08-05 Impact factor: 54.908

Review 2. Differentiating factors between erythropoiesis-stimulating agents: an update to selection for anaemia of chronic kidney disease.

Authors: Walter H Hörl
Journal: Drugs Date: 2013-02 Impact factor: 9.546

Review 3. Regulatory considerations in oncologic biosimilar drug development.

Authors: Judith C Macdonald; Helen Hartman; Ira A Jacobs
Journal: MAbs Date: 2015 Impact factor: 5.857

Review 4. Biosimilar drugs: Current status.

Authors: Rajiv Kumar; Jagjit Singh
Journal: Int J Appl Basic Med Res Date: 2014-07

5. Biosimilar therapeutics-what do we need to consider?

Authors: Huub Schellekens
Journal: NDT Plus Date: 2009-01

6. Acquired Pure Red Cell Aplasia Following Recombinant Erythropoietin (Darbepoetin-alfa) Therapy.

Authors: Somanath Padhi; Gayatri Behera; Sandeep Abhijit Pattnaik; Prabodh Kumar Das; Amit Kumar Adhya; Susama Patra
Journal: Indian J Nephrol Date: 2019-09-06

6 in total